Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Calcium channel blockers.

¹Boston University School of Medicine, Massachusetts.

The Medical Clinics of North America

|January 1, 1988

Summary

This summary is machine-generated.

Calcium channel blockers, initially for angina, show broad utility. These drugs effectively treat diverse conditions including hypertension, cardiomyopathy, and neurological disorders like migraine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical characteristics of youths with substance use problems and implications for residential treatment.

Psychiatric services (Washington, D.C.)·2001

Same author

Long-term prognostic value of exercise testing in men and women from the Coronary Artery Surgery Study (CASS) registry.

The American journal of cardiology·1995

Same author

Significance of silent myocardial ischemia during exercise testing in women: report from the Coronary Artery Surgery Study.

American heart journal·1995

Same author

Calcium antagonists in the treatment of ischemic heart disease: angina pectoris.

Coronary artery disease·1994

Same author

Are all calcium antagonists equally effective for reducing reinfarction rate?

The American journal of cardiology·1993

Same author

Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial.

The American journal of cardiology·1993

Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026

Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026

Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026

Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026

Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026

Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026

See all related articles

Area of Science:

Pharmacology
Cardiology
Neurology

Background:

Calcium channel blockers (CCBs) were first developed for angina treatment.
Their vasodilatory and electrophysiological effects suggest wider therapeutic potential.

Purpose of the Study:

To review the expanded therapeutic applications of calcium channel blockers beyond their initial indications.
To highlight the diverse conditions where CCBs have demonstrated efficacy.

Main Methods:

Literature review of clinical studies and pharmacological data.
Analysis of evidence supporting CCB use in various cardiovascular, respiratory, and neurological conditions.

Main Results:

CCBs are effective in managing pulmonary and systemic hypertension.

Related Experiment Videos

Evidence supports their use in hypertrophic cardiomyopathy, arrhythmias, and Raynaud's syndrome.

Emerging data indicate utility in asthma, esophageal spasm, cerebral arterial spasm, and migraine.

Conclusions:

Calcium channel blockers possess a broader therapeutic spectrum than initially recognized.
Their versatile mechanisms of action make them valuable in treating a wide array of medical conditions.
Further research may uncover additional applications for these essential medications.